Indianapolis IN) agreed to acquire
ImClone Systems Inc.
Bristol-Myers currently owns approximately 17% of all outstanding shares of
ImClone, a leader in the development of antibodies for treating cancer.
Repligen Corporation (Waltham, MA) has reached a settlement with
ImClone Systems in the lawsuit against
ImClone for infringement of United States Patent 4,663,281 based on
ImClone's manufacture and sale of Erbitux.
recently completed architectural, engineering, and design assignments for
ImClone at its headquarters campus on Chubb Way in Branchburg, New Jersey.
ImClone Systems Incorporated (NASDAQ: IMCL) and UCB have entered into a worldwide strategic partnership for the development and commercialization of CDP-791, a novel, investigational antibody targeting the vascular endothelial growth factor receptor-2 (VEGFR-2) that is currently being developed by UCB.
In early 2002, when she was first questioned by the reds, all the news outlets reported speculation, based on anonymous government sources, that she had sold the last remnant of her
ImClone stock on December 27, 2001, because her buddy,
ImClone founder and CEO Sam Waksal, had told her that the Food and Drug Administration was about to reject an application for Erbitux, the company's highly touted cancer drug.
In a plea bargain announced October 2, the 27-year-old former assistant to Merrill Lynch financial adviser Peter Bacanovic, who was Stewart's broker, pleaded guilty to misdemeanor charges of misleading federal investigators about the real reason for Stewart's sale last December of 3,928 shares of the drug company
ImClone Systems' stock, valued at about $228,000.
ImClone Systems Incorporated (Nasdaq:IMCL) has announced the issuance of a Japanese patent, No.
If a takeover of
ImClone is successful, it would mark the end of one of the most colorful corporate sagas in biotech history, complete with the jailing of founder Sam Waksal and his friend Martha Stewart, the style guru caught for lying to investigators over her suspicious trading in
ImClone stock.
one of New Jersey's fastest growing general contracting firms, has recently completed a high-end renovation project on behalf of
ImClone Systems Incorporated at 33 Chubb Way in Branchburg, N.
